Chiasma
William Ludlam is the Senior Vice President of Clinical Development and Medical Affairs at Chiasma. Prior to this, they served as the Senior Medical Director at Novartis in US Clinical Development and Medical Affairs for the Pituitary Disorders and Rare Diseases Franchise. Before that, they were the Medical Director at Swedish Medical Center, where they established and oversaw the Seattle Pituitary Center. Ludlam has also served as a Medical Director at OHSU | Oregon Health & Science University.
William Ludlam's educational career includes a Doctor of Medicine (M.D.) from Albert Einstein College of Medicine, a Doctor of Philosophy (Ph.D.) in Developmental Neuroscience/Molecular Biology from Albert Einstein College of Medicine, and a Bachelor's Degree in Chemistry from Whittier College.
They are on a team with Mark J. Fitzpatrick - President, Shoshie Katz - VP Quality Assurance & Regulatory Affairs, and Joe Lyons - Executive Director Human Resources. William Ludlam reports to Raj Kannan, Chief Executive Officer.
This person is not in any offices
Chiasma
1 followers
Chiasma is a late-stage biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of therapies that are available today only by injection.